Case Details
- Citation: [2016] SGHCR 3
- Title: La Dolce Vita Fine Dining Co Ltd and another v Deutsche Bank AG and another and another matter
- Court: High Court of the Republic of Singapore
- Date: 26 February 2016
- Judges: Tan Teck Ping Karen AR
- Coram: Tan Teck Ping Karen AR
- Case Number: Originating Summons No 305 of 2015 and Originating Summons No 307 of 2015
- Tribunal/Court: High Court
- Plaintiff/Applicant: La Dolce Vita Fine Dining Co Ltd and another
- Defendant/Respondent: Deutsche Bank AG and another and another matter
- Legal Areas: Civil Procedure — Pre-Action Discovery
- Statutes Referenced: Banking Act; Book Evidence Act; Evidence Act; First Schedule of the Supreme Court of Judicature Act; International Arbitration Act; Third Schedule of the Banking Act
- Cases Cited: [2016] SGHCR 3 (as reported); UMCI Ltd v Tokio Marine & Fire Insurance Co (Singapore) Pte Ltd and others [2006] 4 SLR(R) 95; Dorsey James Michael v World Sport Group Pte Ltd [2014] 2 SLR 208
- Judgment Length: 17 pages, 8,961 words
- Counsel (OS 305/2015 and OS 307/2015): Mr Harpreet Singh, S.C., Mr Paul Sandosham, Ms Tan Mingfen, Mr Jerald Foo, Ms Elsa Goh (Cavenagh Law LLP) for the plaintiffs; Ms Tan Xeauwei (Allen & Gledhill LLP) for the first defendant in OS 305/2015; Mr Chua Sui Tong and Mr Daniel Chan (WongPartnership LLP) for the first defendant in OS 307/2015; Mr Edmund Kronenburg and Ms Grace Loke (Braddell Brothers LLP) for the second defendant in both applications
Summary
La Dolce Vita Fine Dining Co Ltd and another v Deutsche Bank AG and another and another matter concerned two applications for pre-action discovery against Singapore-incorporated banks, made by investors who had commenced arbitration proceedings in China against the sellers of a food and beverage business. The plaintiffs alleged that the founder-sellers had fraudulently manipulated the target company’s accounting records to inflate the purchase price. The plaintiffs sought disclosure from the banks of documents relating to accounts said to be controlled by the founder, in order to trace and identify where the allegedly misappropriated funds had gone.
The High Court (Tan Teck Ping Karen AR) confirmed that the court has statutory power under O 24 r 6(5) of the Rules of Court to order discovery against non-parties, and that this power overlaps with the court’s inherent jurisdiction to grant Norwich Pharmacal-type relief. However, the court emphasised that pre-action disclosure is intrusive and must be confined to what is strictly necessary. The court applied the “justness and necessity” framework, and considered whether the plaintiffs had demonstrated a likely prospect of subsequent proceedings in Singapore, as well as whether the Banking Act and Evidence Act regime permitted the requested disclosure from the banks.
What Were the Facts of This Case?
The plaintiffs were a buyer and an investor within a private equity structure associated with the CVC Group. The investor was the majority shareholder of Dolce Vita Fine Dining Holdings Limited (“EquityCo”), and the buyer was wholly owned by EquityCo. The founder of the acquired business, Zhang Lan (“Founder”), was alleged to have controlled and manipulated the financial information relied upon during the acquisition.
Through a series of transactions, the plaintiffs acquired shares in a Cayman Islands company, South Beauty Investment Company Limited (“Company”), and in EquityCo itself. The total consideration paid for the shares in the Company was US$235,066,678, and the consideration paid for the shares in EquityCo was US$51,784,209. The payments were made into the Founder’s Hong Kong bank account held with Bank J. Safra Sarasin, Hong Kong Branch (“Bank Sarasin”). The plaintiffs alleged that the Founder represented to CVC prior to the acquisition that the group was a thriving and successful brand resistant to economic and consumption slowdown in the People’s Republic of China.
After completion, the plaintiffs discovered in 2015 what they alleged to be manipulation of the Company’s accounting and financial records in 2013. The alleged manipulation was said to have inflated the valuation of the Company, inducing the plaintiffs to pay an artificially high price. An expert report by FTI Consulting dated 25 February 2015 concluded that there was pervasive manipulation of transaction sales data between January and April 2014, and that similar manipulation was highly likely in 2013. On the basis of these findings, the plaintiffs commenced separate arbitration proceedings against the sellers in the China International Economic and Trade Arbitration Commission (“CIETAC”). The arbitration claims sought rescission of the sale and purchase agreement, return of the purchase price, and damages (or alternatively damages/indemnity if rescission was not granted), grounded in allegations of fraudulent misrepresentation and breach of warranties.
To support their arbitration claims and to trace assets, the plaintiffs obtained interim relief in Hong Kong and Singapore. The Hong Kong court granted injunctions restraining the Founder from disposing of assets worldwide, disclosure orders requiring disclosure of assets above a threshold, disclosure orders against Bank Sarasin, and evidence preservation orders. In Singapore, the court granted injunctions prohibiting the Founder from disposing of or dealing with or diminishing the value of her assets in Singapore. Various banks were notified of the Singapore injunctions.
Crucially for the pre-action discovery applications, the plaintiffs believed that the Founder owned a British Virgin Islands company, Success Elegant Trading Limited (“SE”), until 4 June 2014 when she transferred her sole share to Asiatrust. The plaintiffs believed that SE had accounts with the banks targeted in the applications: Credit Suisse AG (“CS”) in OS 307/2015 and Deutsche Bank AG (“DB”) in OS 305/2015. The plaintiffs sought confirmation and were informed that steps had been taken to comply with the Singapore injunctions to ensure no dealings in monies or assets held in the relevant accounts.
Despite the injunctions, the plaintiffs believed that the Founder had transferred funds from the Hong Kong account to the CS and DB accounts to put the funds out of reach. Accordingly, they filed the present applications for discovery against the banks. Their stated purposes were to identify third parties for potential proceedings, ascertain the full nature of the wrongdoing to plead properly, and trace assets to support proprietary claims against the Founder and third parties.
What Were the Key Legal Issues?
The court identified three principal issues. First, whether the requirements for obtaining an order for pre-action discovery under O 24 r 6(5) of the Rules of Court and/or the court’s inherent jurisdiction were satisfied. This required the court to consider the scope and limits of non-party disclosure, particularly in the context of intrusive pre-action measures.
Second, the court had to determine whether the plaintiffs had shown a likely prospect of subsequent proceedings being held in Singapore. This requirement is linked to the statutory framework in O 24 r 6(5) read with paragraph 12 of the First Schedule of the Supreme Court of Judicature Act (“SCJA”). In other words, the court needed to be satisfied that the discovery sought was not merely exploratory, but connected to a realistic litigation pathway in Singapore.
Third, the court had to consider whether the Banking Act and section 175 of the Evidence Act permitted the requested discovery from the banks. The plaintiffs sought disclosure of customer information and bank documents, and therefore needed to rely on exceptions within the Third Schedule of the Banking Act. This raised a regulatory and evidential question: even if the court had general procedural power to order discovery, the statutory banking secrecy and evidential restrictions could limit what could be compelled.
How Did the Court Analyse the Issues?
The court began by restating the legal basis for pre-action discovery against non-parties. Under O 24 r 6(5), the court may order discovery of documents before commencement of proceedings, or by a person who is not a party, for the purpose of or with a view to identifying possible parties to proceedings, where the court thinks it just to make such an order and on terms it thinks just. The court observed that these words give statutory effect to the classic Norwich Pharmacal order, which is traditionally sought where information is needed to identify a potential defendant so that proceedings may be commenced against them.
In addition, the court confirmed that it retains inherent jurisdiction to order disclosure from a non-party. This was supported by the earlier decision in UMCI Ltd v Tokio Marine & Fire Insurance Co (Singapore) Pte Ltd and others [2006] 4 SLR(R) 95 (“Tokio Marine”), where the court recognised overlap between O 24 r 6(5) and inherent Norwich Pharmacal-type relief. The practical implication is that the court’s power is not confined to the narrow “identification of parties” scenario, but must still be exercised consistently with the principles governing Norwich Pharmacal orders.
However, the court then emphasised the caution from the Court of Appeal in Dorsey James Michael v World Sport Group Pte Ltd [2014] 2 SLR 208 (“Dorsey James”). The Court of Appeal highlighted that pre-action disclosure is quintessentially intrusive, especially when it involves individuals or entities that may ultimately not be parties to the litigation. The application must therefore be confined to what is strictly necessary for disposing fairly of the cause or matter or for saving costs in pending or potential proceedings. The court must ultimately decide whether the making of any order is “just” in all the circumstances, and must discourage “deep-sea fishing” for information.
Against this backdrop, the court treated “justness and necessity” as the prescribed test for pre-action discovery. This means that even if the plaintiffs can articulate a legitimate purpose—such as tracing assets or identifying third parties—the court will still scrutinise whether the scope of the requested documents is proportionate and necessary, and whether the request is genuinely connected to the likely issues in the anticipated proceedings.
On the second issue, the court considered whether the plaintiffs had shown a likely prospect of subsequent proceedings in Singapore. Although the plaintiffs had already commenced CIETAC arbitration in China, the court still had to assess whether the discovery sought would be used in proceedings in Singapore, or whether Singapore proceedings were realistically contemplated. The statutory framework in O 24 r 6(5) read with paragraph 12 of the First Schedule of the SCJA requires this connection. The court’s approach reflects a policy choice: Singapore courts should not be used as a mechanism to obtain broad disclosure for foreign litigation without a sufficient nexus.
On the third issue, the court addressed the special statutory regime for banking secrecy and evidential admissibility. The plaintiffs sought disclosure of customer information and documents from the banks. The court therefore had to consider whether the Banking Act, read together with section 175 of the Evidence Act, permitted the banks to disclose the requested documents, and whether the plaintiffs could rely on an exception within the Third Schedule of the Banking Act. This analysis is particularly important because banks are subject to statutory constraints, and a procedural discovery order cannot override substantive statutory limits.
Although the extracted text provided here truncates the later parts of the judgment, the structure of the court’s reasoning indicates that it would have proceeded to apply the Norwich Pharmacal principles to the specific categories of documents sought, assess whether the plaintiffs’ purposes were sufficiently linked to the anticipated proceedings, and then determine whether the Banking Act exceptions were engaged. In such cases, courts typically require the applicant to specify the documents sought with sufficient clarity, demonstrate relevance to the alleged wrongdoing, and show that the disclosure is necessary rather than speculative.
What Was the Outcome?
The High Court’s decision addressed the plaintiffs’ applications for pre-action discovery against Deutsche Bank AG and Credit Suisse AG. The court’s reasoning reflects a careful balancing exercise between the plaintiffs’ need to trace potentially fraudulently transferred funds and the intrusive nature of compelling non-party banks to disclose customer information.
While the provided extract does not include the final dispositive orders, the judgment’s framing indicates that the court would have determined whether the applications met the “justness and necessity” threshold and whether the Banking Act and Evidence Act framework permitted the requested disclosure. The outcome therefore turned on both procedural propriety (pre-action discovery principles) and substantive legality (banking secrecy exceptions).
Why Does This Case Matter?
This case is significant for practitioners because it illustrates how Singapore courts approach pre-action discovery against non-parties—particularly banks—where the applicant seeks information to trace assets and identify wrongdoing in support of fraud-based claims. The court’s reliance on Dorsey James underscores that pre-action disclosure is not a tool for exploratory fishing. Applicants must show necessity, relevance, and a just basis for intrusive orders.
Second, the case highlights the interaction between civil procedure and financial regulatory constraints. Even where the court has procedural power to order discovery, the Banking Act and Evidence Act regime may restrict what can be compelled from banks. Practitioners seeking discovery from financial institutions must therefore plan the application around statutory exceptions, and not merely around procedural rules.
Third, the decision is useful for lawyers dealing with cross-border or multi-forum disputes. The plaintiffs had already commenced CIETAC arbitration in China and sought discovery in Singapore. The court’s focus on whether there is a likely prospect of subsequent proceedings in Singapore demonstrates that Singapore courts will scrutinise the nexus to Singapore litigation. This is a practical reminder that pre-action discovery in Singapore is not automatically available simply because the applicant is pursuing proceedings elsewhere.
Legislation Referenced
- Banking Act
- Book Evidence Act
- Evidence Act
- First Schedule of the Supreme Court of Judicature Act
- International Arbitration Act
- Third Schedule of the Banking Act
Cases Cited
- UMCI Ltd v Tokio Marine & Fire Insurance Co (Singapore) Pte Ltd and others [2006] 4 SLR(R) 95
- Dorsey James Michael v World Sport Group Pte Ltd [2014] 2 SLR 208
Source Documents
This article analyses [2016] SGHCR 3 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.